• A-1210477: Precision MCL-1 Inhibitor for Apoptosis Research

  2026-05-27

  A-1210477 is a best-in-class MCL-1 inhibitor enabling targeted induction of mitochondrial apoptosis in cancer cells, with superior potency and selectivity. This guide translates cutting-edge research into actionable protocols and troubleshooting strategies for reliable apoptosis assays.

• Proteoform-Specific Drug Interactions in Native Membrane Env

  2026-05-26

  This study pioneers the direct analysis of proteoform-specific drug interactions within native cell signaling environments, using advanced mass spectrometric techniques. Its findings clarify how post-translational modifications and alternative splicing affect membrane protein–ligand interactions, with implications for the selectivity and off-target profiles of PDE5 inhibitors such as Vardenafil.

• Phosbind Biotin LC: Practical Guide for Phosphorylated Prote

  2026-05-26

  Phosbind Biotin LC addresses the need for sequence-independent detection of phosphorylated proteins in Western Blot workflows, especially when phospho-specific antibodies are limiting or unavailable. This phosphate-binding reagent is optimized for use on PVDF membranes and should not be used in aqueous-only protocols or stored long-term in solution.

• RAB31 Controls ESCRT-Independent Exosome Biogenesis Pathways

  2026-05-25

  This article examines new evidence that RAB31 marks and regulates an ESCRT-independent pathway for exosome biogenesis, acting through direct interactions with flotillin proteins and GTPase-activating proteins to coordinate ILV formation and prevent MVE degradation. These findings highlight a dual regulatory mechanism distinct from canonical ESCRT-dependent models, with implications for exosome research and protein sorting.

• Structure-Based Discovery of SARS-CoV-2 NSP15 Inhibitors

  2026-05-25

  This study identifies thymopentin and oleuropein as potent inhibitors of SARS-CoV-2 NSP15 via structure-based virtual screening and molecular dynamics validation. The findings provide a foundation for future antiviral strategies targeting viral immune evasion and highlight the value of computational drug discovery.

• Z-WEHD-FMK: Precision Caspase Inhibition for Inflammation Re

  2026-05-24

  Z-WEHD-FMK (Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK) empowers researchers to dissect caspase-driven inflammation and apoptosis in infectious disease and cancer models. Its irreversible, cell-permeable action uniquely enables mechanistic studies of pyroptosis and host-pathogen interplay, as exemplified by recent advances in lung tumorigenesis research.

• HOXC8 Suppresses Pyroptosis in NSCLC via Caspase-1 Regulatio

  2026-05-23

  This study uncovers a mechanism by which HOXC8 inhibits pyroptotic cell death in non-small cell lung carcinoma (NSCLC) through suppression of caspase-1 transcription. The findings clarify how HOXC8 recruits HDAC1/2 to the caspase-1 promoter, limiting inflammatory cell death and influencing tumorigenesis, with implications for targeting caspase signaling in cancer and inflammation research.

• Hoechst 33342/PI Double Staining Kit: Practical Research Gui

  2026-05-22

  The Hoechst 33342/PI Double Staining Kit provides a proven method for distinguishing viable, apoptotic, and necrotic cells through dual fluorescent staining, specifically addressing research needs in cell death analysis. This kit is not suitable for diagnostic or clinical use and is strictly intended for basic research workflows requiring chromatin condensation and cell membrane integrity assessment.

• Prolonging Corneal Epithelial Progenitor Expansion with 6C M

  2026-05-22

  This study introduces a novel serum-free 6C medium that markedly extends the proliferative activity of mouse corneal epithelial cells (mCEC) both in vitro and in vivo. By targeting multiple signaling pathways—including Notch via DAPT—the protocol enables robust expansion of epithelial progenitor populations, supporting advances in corneal regenerative medicine and transplantation.

• Micro- and Nanoplastics Elevate Pulmonary Fibrosis Risk in M

  2026-05-21

  This study systematically dissects how microplastics and nanoplastics of various polymer types and sizes induce pulmonary fibrosis in vivo and in vitro. The findings reveal size- and polymer-dependent toxicity, with polystyrene nanoplastics showing the greatest risk, and implicate the FXR-YAP1 axis as a mechanistic driver, providing a foundation for future risk assessment and mechanistic research in environmental toxicology.

• Calcium Ions Modulate Amyloid Beta (1-40) Aggregation Dynami

  2026-05-21

  The referenced study leverages supercritical angle Raman and fluorescence spectroscopy to dissect how calcium ions (Ca2+) alter the aggregation and membrane interactions of Amyloid Beta-Peptide (1-40) (human). These findings clarify the biophysical mechanisms underpinning membrane protection versus disruption, providing new avenues for Alzheimer's disease research on aggregation-driven neurotoxicity.

• YM-155 Hydrochloride: Precision Survivin Inhibitor for Cance

  2026-05-20

  YM-155 hydrochloride is a potent, nanomolar survivin inhibitor validated for robust tumor regression in xenograft and in vitro models. This article details its selectivity, protocol parameters, and scientific limitations for apoptosis inhibitor research.

• Enhancing Immunoassay Sensitivity with HyperFluor 488 Goat A

  2026-05-20

  HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody delivers exceptional signal amplification in immunofluorescence, Western blot, and flow cytometry. Its robust specificity and Alexa Fluor 488 conjugation empower researchers to achieve high-sensitivity, reproducible detection of human IgG, even in complex samples.

• Exo1: Precision Membrane Trafficking Inhibition in Exocytic

  2026-05-19

  Exo1 (methyl 2-(4-fluorobenzamido)benzoate) empowers researchers with selective, rapid inhibition of the exocytic pathway, uniquely differentiating Golgi-ER trafficking effects from legacy inhibitors. Its distinct mechanism enables advanced exocytosis assays and novel strategies for studying extracellular vesicle biogenesis and tumor communication.

• Estradiol Benzoate: Mechanistic Leverage for Translational S

  2026-05-19

  This thought-leadership article examines how Estradiol Benzoate, a high-affinity estrogen receptor alpha agonist, acts as both a mechanistic probe and a strategic asset for translational researchers. We bridge molecular pharmacology, assay optimization, and workflow design, integrating evidence from recent literature and product intelligence, to empower advanced estrogen receptor signaling research.

405 records 7/27 page Previous Next First page 上5页 678910 下5页 Last page